Trial intelligence / Profile preview

Glecaprevir/pibrentasvir in renally impaired adults with chronic hepatitis C

2016-004182-60Phase 3Completed

Sponsor

AbbVie Inc.

Start

Mar 2017

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1